购物车
您的购物车当前为空
CD30/TNFRSF8 Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with hFc and Avi tag. The predicted molecular weight is 67.02 kDa and the accession number is P28908-1.
别名 tumor necrosis factor receptor superfamily, member 8, Ki-1, D1S166E, CD30
CD30/TNFRSF8 Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with hFc and Avi tag. The predicted molecular weight is 67.02 kDa and the accession number is P28908-1.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 μg | ¥ 987 | 6-8日内发货 | |
| 10 μg | ¥ 1,700 | 6-8日内发货 | |
| 20 μg | ¥ 2,940 | 5日内发货 | |
| 50 μg | ¥ 4,730 | 5日内发货 | |
| 100 μg | ¥ 7,880 | 5日内发货 |
| 产品描述 | CD30/TNFRSF8 Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with hFc and Avi tag. The predicted molecular weight is 67.02 kDa and the accession number is P28908-1. |
| 生物活性 | Immobilized Human CD30L hFc at 2 μg/mL (100 μL/well) can bind Human CD30/TNFRSF8 hFc & AVI, Biotinylated, the EC50 of Human CD30/TNFRSF8 hFc & AVI, Biotinylated is 30-130 ng/mL. |
| 研究背景 | CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor (TNFR) superfamily. CD30 protein is expressed by activated, but not resting, T and B cells. CD30 can regulate proliferation of lymphocytes and may also play an important role in human immunodeficiency virus replication. As a regulator of apoptosis, CD30 protein induces cell death or proliferation, depending on the cell type, and has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. CD30 protein expression is upregulated in various hematological malignancies, including Reed-Sternberg cells in Hodgkin's disease (HD), anaplastic large cell lymphoma (ALCL) and subsets of Non-Hodgkin's lymphomas (NHLs), and CD30 is also linked to leukocytes in patients with chronic inflammatory diseases, including lupus erythematosus, asthma, rheumatoid arthritis and atopic dermatitis (AD).Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| 种属 | Human |
| 表达系统 | HEK293 Cells |
| 标签 | C-hFc-Avi |
| 蛋白编号 | P28908-1 |
| 蛋白构建 | A DNA sequence encoding the human TNFRSF8 (NP_001234.2) (Met1-Lys379) was expressed with a c-terminal AVI tagged Fc region of human IgG1 at the C-terminus (Fc-AVI). The expressed protein was biotinylated in vivo by the Biotin-Protein ligase (BirA enzyme) which is co-expressed. Predicted N terminal: Phe19 |
| 蛋白纯度 | > 90 % as determined by SDS-PAGE. |
| 蛋白性状 | Lyophilized powder |
| 缓冲液 | Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.4. Typically, a mixture containing 5% to 8% trehalose, mannitol, and 0.01% Tween 80 is incorporated as a protective agent before lyophilization. |
| 复溶方法 | A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information. |
| 别名 | tumor necrosis factor receptor superfamily, member 8, Ki-1, D1S166E, CD30 |
| 内毒素 | < 1.0 EU/μg of the protein as determined by the LAL method. |
| 分子量 | 67.02 kDa (predicted); 110.33 kDa (reducing conditions) |
| 运输方式 | In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice. |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多